http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201821065-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bed23dd6f3c0c351cd3bfde9c1b11fe
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_331c7c18f470f75a91564c6b5d6542ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b036c618d2930293371365e61c1a5e28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b83053c86c1ccd158916b2dbf9fc30f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26593a7f6ddc79e1fd3f560c2ce19975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b4328f32cfbc756282c03a1bc27d970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_207772aca1ab092d5227d0eb155bf28f
publicationDate 2018-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201821065-A
titleOfInvention Oral capsule compound formula of dutasteride and tadalafil
abstract The present invention relates to a capsule compound formulation comprising dutasteride represented by formula I, tadalafil represented by formula II, a fatty acid ester derivative having 8 to 10 carbon atoms, and polysorbate Or polyoxyglyceride-based surfactants, where the two drugs are dissolved:
priorityDate 2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415734775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450600746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448881833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53630264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4678093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22677836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415792106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423040663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496195

Total number of triples: 48.